Tulin Gokmen Yildirim

Tulin Gokmen Yildirim

Auto-generated profile, based on publicly available information

Tulin Gokmen Yildirim

SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, İZMİR DR. BEHÇET UZ ÇOCUK HASTALIKLARI VE CERRAHİSİ SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2019 in Retina
Verified
Journal Article
Closed access
SSSelim Sancak
Selim Sancak
HTHandan Hakyemez Toptan
Handan Hakyemez Toptan
TYTulin Gokmen Yildirim
Tulin Gokmen Yildirim
GKGuner Karatekin
Guner Karatekin
FOFahri Ovali
Fahri Ovali
Purpose: To study the association between thrombocytopenia and retinopathy of prematurity (ROP). Methods: The case-control study was conducted on preterm newborns with ROP between January 2011 and January 2014, retrospectively. The patients were assigned into two groups: Cases required intervention and controls developed no or Stage I ROP. Results: Eighty-one premature infants with Type I ROP were enrolled to the study with a mean gestational age of 27.6 ± 2.1 (range: 24–32) weeks and birth weight of 993 ± 292 (range: 560–1,930) g. Mean follow-up time was 38.3 ± 2.7 weeks (min: 32 and max: 46 weeks). Cases were individually matched to a set of controls (1:1 ratio). Thrombocytopenia (<150.000/mm3) was seen in 58 (71.6%) of the cases with Type I ROP, whereas only 17 (21%) of the controls had thrombocytopenia (P < 0.001). Logistic regression analysis showed that bronchopulmonary dysplasia and thrombocytopenia were significantly associated with Type I ROP (relative risk [95% confidence interval]: 4.19 [1.47–12] and 6.69 [2.83–15.9], respectively). The thrombocytopenia ratio (P = 0.073), thrombocytopenia 1 week before intervention (P = 0.076) and platelet transfusion ratio (P = 0.062) tended to be higher in Zone I ROP compared with Zone II ROP. Conclusion: In our study, there was a significant association between thrombocytopenia and Type I ROP.

1 January 2022 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
PDF file
SOSENEM Alkan Ozdemir
SENEM Alkan Ozdemir
ÖYÖzlem Yilman
Özlem Yilman
ŞÇŞebnem Çalkavur
Şebnem Çalkavur
TYTüli̇n Gökmen Yildirim
Tüli̇n Gökmen Yildirim
Background/aim: We aimed to discuss term infants who are given surfactant due to respiratory disorder according to the underlying etiology, the dose of surfactant administration, and the need for repeated surfactant administration. Materials and methods: In this retrospective study infants hospitalized in the 4th level neonatal intensive care unit during January 2019 and December 2021 and administered surfactant due to respiratory distress were included. Term infants given surfactant due to respiratory failure were included in the study through the data recording system. The number of surfactant doses, indications for administration, mortality, duration of hospitalization, intubation time, and inotrope use were recorded in the infants included in the study. Results: During the two-year period, 1250 infants were hospitalized in our neonatal intensive care unit. Of those, 56 infants received surfactant replacement therapy for severe respiratory failure. There were 30 infants with pneumonia, 4 infants with meconium aspiration syndrome (MAS), and 22 infants with transient tachypnea of the newborn (TTN). It was seen that single-dose administration was higher in patients with TTN (p = 0.01), while multiple-dose surfactant administration was more common in patients with MAS, resulting in a statistical difference (p = 0.02). Mortality was lower, especially in cases given early surfactant administration and this situation was statistically significant (p < 0.001). Duration of intubation was 5.05 ± 4.7 days in early surfactant administration group and 8.0 ± 6.1 days in late surfactant administration group. This difference was statistically significant (p = 0.04). While early surfactant application was statistically higher in the TTN group (p = 0.007), late surfactant application was statistically higher in the pneumonia group (p = 0.001). Conclusion: Despite the difference on administration time and repeat dose interval due to etiology, surfactant treatment is improving the respiratory distress of term infants.

13 December 2023 in Gynecology Obstetrics & Reproductive Medicine
Verified
Journal Article
Open access
PDF file
OYOzlem Yilman
Ozlem Yilman
SOSENEM Alkan Ozdemir
SENEM Alkan Ozdemir
SCSebnem Calkavur
Sebnem Calkavur
TYTulin Gokmen Yildirim
Tulin Gokmen Yildirim
OBJECTIVE: We aimed to evaluate surfactant frequency and surfactant indications, as well as lung problems in late preterm infants. STUDY DESIGN: This retrospective and cross-sectional study was carried out by HSU Izmir Dr. Behcet Uz Pediatric Diseases and Surgery Research and Training Hospital. Infants who were born late preterm between January 2016 and January 2022 were hospitalized in the NICU due to respiratory distress in the first 24 hours. Lung problems and surfactant administration of these infants were evaluated. The frequency of surfactant dosages, their indications, and their effects were examined. As the control group, patients who were admitted to the NICU in the same period due to respiratory distress with similar indications but did not receive surfactant were considered. RESULTS: It was observed that surfactant was not administered to 105 infants and surfactant was administered to 106 infants. The median gestational week of the infants included in the study was 35 (34/36) weeks and the birth weight was 2185 (1780/2590) grams. A significant difference was observed in birth weight between the groups (p<0.001). Invasive ventilation was required in 52.1% of all cases and noninvasive ventilation was required in 33.6%. In the delivery room, the need for resuscitation and intubation was higher in the group requiring surfactant (p=0.001). The most common lung pathology in the surfactant group was RDS. CONCLUSION: It must not be forgotten that infants who are born late preterm infants are preterm infants and the evaluation of antenatal steroid administration must not be ignored.

1 January 2019 in Journal of Dr Behcet Uz Children s Hospital
Verified
Journal Article
Open access
RARuya Atesli
Ruya Atesli
EEEzgi Yangin Ergon
Ezgi Yangin Ergon
SOSENEM Alkan Ozdemir
SENEM Alkan Ozdemir
FKFerit Kulali
Ferit Kulali
MYMeral Yıldız
Meral Yıldız
ŞÇŞebnem Çalkavur
Şebnem Çalkavur

21 June 2024 in İzmir Tıp Fakültesi Dergisi
Verified
Journal Article
Open access
OKOğuz Han Kalkanlı
Oğuz Han Kalkanlı
SOSENEM Alkan Ozdemir
SENEM Alkan Ozdemir
ŞÇŞebnem Çalkavur
Şebnem Çalkavur
TYTülin Gökmen Yıldırım
Tülin Gökmen Yıldırım
Amaç: Sarılık yenidoğanlarda sıklıkla gözlenen klinik bir durumdur. Yenidoğan sarılığı genellikle fizyolojik bir durum olmakla birlikte nadiren yüksek bilirübin düzeyine bağlı olarak akut veya kronik bilirübin ensefalopatisine neden olabilir. Çalışmamızdaki amaç yenidoğan dönemindeki hiperbilirübinemi nedeniyle kan değişimi yapılan hastalarla ilgili klinik deneyimlerimizi paylaşmaktır. Gereç ve Yöntemler: Ocak 2017 ile Ağustos 2022 tarihleri arasında, Sağlık Bilimleri Üniversitesi Dr. Behçet Uz Çocuk Hastalıkları ve Cerrahisi Eğitim ve Araştırma Hastanesi yenidoğan yoğunbakım kliniğimizde yenidoğan hiperbilirübinemisi nedeniyle kan değişimi yapılan ve ≥35 gestasyonel hafta yenidoğanlar retrospektif olarak incelendi. Hastaların demografik verileri, etiyolojik faktörleri, kan değişim öncesi ve sonrası laboratuvar değerleri, kan değişim süresi ve komplikasyonları, hiperbilirübinemiye bağlı akut ve kronik dönem komplikasyonları kayıt altına alınarak incelendi. Bulgular: Toplam 45 yenidoğana 47 kez kan değişimi yapıldı. Hastaların ortalama gestasyonel haftası 38.2 (±1.4) hafta, doğum ağırlığı 3290 g (±480) ve hastaneye ortalama başvuru süresi postnatal 3.6 gündü (±2.1). Kan değişim süresi ortalama 86.6 (±23.4) dakika olup en sık kan değişim nedeni ABO kan grubu uygunsuzluğuna (%24.4) bağlıydı. 13 hastada hiperbilirübinemi nedeni tespit edilemedi. Kan değişimine bağlı en sık komplikasyon trombositopeni (%95.5), sonrasında hiperglisemi (%86.4) olarak gözlendi. Başvuru anında hastaların %6.6’sında orta ve ileri derecede akut bilirübin ensefalopatisi gözlenmesine rağmen sonraki dönem izlemlerde %17.7’sinde kronik bilirübin ensefalopatisi izlendi. Kan değişimine bağlı mortalite görülmedi. Sonuç: Yenidoğanın ciddi hiperbilirübinemisinde bilirübin ensefalopatisi hastaların büyük bir çoğunluğunda ilk başvuru anında gözlenmeyebilir. Kan değişim her ne kadar serum bilirübin düzeyini hızlı bir şekilde düşürse de kronik bilirübin ensefalopatisi ileri dönemde gözlenebilir.

1 April 2023 in Pediatric Academic Case Reports
Verified
Journal Article
Open access
PDF file
EEEzgi Yangin Ergon
Ezgi Yangin Ergon
RARuya Atesli
Ruya Atesli
FKFerit Kulali
Ferit Kulali
SOSENEM Alkan Ozdemir
SENEM Alkan Ozdemir
MYMeral Yıldız
Meral Yıldız
ŞÇŞebnem Çalkavur
Şebnem Çalkavur
Neonatal gastro ntest nal perforat on (GIP) s a pathology that can be observed n a h ghly heterogeneous group rang ng from premature and low b rth we ght bab es to healthy term bab es. Here, we report two rare cases of GIP n the neonatal per od w th d erent pathologes. Our f rst case presented w th spontaneous ntest nal perforat on n the f rst week of l fe s the perforated Meckelʼs d vert culum. The second case presented w th ntest nal abscess and perforat on s perforated append c t s. Although there are s m lar r sk factors n the etology, the GIP patholog es n the neonatal per od are very d erent from each other and the r common character st cs are that they present w th ntest nal perforat on n the f rst weeks of l fe. The correct d agnos s before the operat on s very challeng ng due to nsu c ent laboratory and mag ng methods. Careful cl n cal observat on and t mely surg cal ntervent on protects aga nst morb d ty and mortal ty due to perforat on.